Componenta (CTH1V) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
5 Jun, 2025Executive summary
Net sales for 2024 were EUR 97.1 million, down 4.6% year-over-year due to lower demand and raw material price indices.
EBITDA increased to EUR 7.9 million (up 48.8%), including a EUR 2.9 million non-recurring income; adjusted EBITDA was EUR 4.9 million, slightly below last year.
Operating profit was EUR 2.6 million, down 31.9% from 2023, with net profit at EUR 0.2 million (EUR 1.5 million in 2023).
Cash flow from operating activities improved significantly to EUR 8.2 million from EUR 1.1 million.
No dividend proposed for 2024.
Financial highlights
Cash and cash equivalents at year-end were EUR 8.7 million, up from EUR 5.3 million.
Unused binding revolving credit facilities stood at EUR 4.0 million.
New working capital loan of EUR 2.0 million and a EUR 3.0 million convertible bond arrangement were secured.
Order book at year-end was EUR 16.7 million, up 14.8% year-over-year.
Capital expenditure including leases was EUR 6.7 million, up 65.6%.
Outlook and guidance
Net sales and adjusted EBITDA are expected to improve in 2025 compared to 2024.
Growth prospects for customers are cautiously optimistic for 2025, but uncertainties remain due to inflation, interest rates, and geopolitical tensions.
Focus areas for 2025 include growth, profitability, new sales, and ramp-up of new production facilities.
Latest events from Componenta
- Net sales and profitability surged, with strong cash and order book growth supporting a positive outlook.CTH1V
Q4 20256 Mar 2026 - Sales and EBITDA surged, order book grew, and liquidity stayed stable amid uncertainty.CTH1V
Q3 202530 Oct 2025 - Sales and profit surged, led by energy and defence, with strong cash flow and positive outlook.CTH1V
Q2 202523 Jul 2025 - Net sales and EBITDA fell, but Q3 improved and acquisitions support future growth.CTH1V
Q3 202413 Jun 2025 - Sales and profit fell, but new contracts and acquisitions signal recovery in H2 2024.CTH1V
Q2 202413 Jun 2025 - Sales and profitability surged, with strong liquidity and a positive outlook for 2025.CTH1V
Q1 20255 Jun 2025